4//SEC Filing
Schwartz Jonathan David 4
Accession 0001140361-25-042856
CIK 0001281895other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 4:05 PM ET
Size
4.7 KB
Accession
0001140361-25-042856
Insider Transaction Report
Form 4
Schwartz Jonathan David
See Remarks
Transactions
- Sale
Common Stock
2025-11-18$2.98/sh−2,545$7,592→ 299,064 total
Footnotes (1)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001726398
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 4:05 PM ET
- Size
- 4.7 KB